SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: Biomaven who wrote (8152)4/21/2003 2:30:24 PM
From: Michael Young  Read Replies (2) | Respond to of 52153
 
Thanks. I just spotted the chart the other day, and did a little fundamental research over the weekend.

INS365 is their dry eye drug. It will be co-promoted with AGN, and management expects it could do north of $500 million eventually. Apparently dry eye affects about 10 million people, with no currently approved treatments.

MIKE